Camptothecin-based prodrug nanomedicines for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Camptothecin-based prodrug nanomedicines for cancer therapy

Published:2023 Issue:44 Volume:15 Page:17658-17697
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Zhang Renshuai¹,Yu Jing²,Guo Zhu¹³,Jiang Hongfei¹^ORCID,Wang Chao¹

Affiliation:

1. Cancer Institute of The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266061, China

2. Qingdao Hospital, University of Health and Rehabilitation Sciences, Qingdao Municipal Hospital, Qingdao, 266071, China

3. The Affiliated Hospital of Qingdao University, Qingdao 266061, China

Abstract

Camptothecin (CPT) is a cytotoxic alkaloid that attenuates the replication of cancer cells via blocking DNA topoisomerase 1.

Funder

Natural Science Foundation of Shandong Province

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2023/NR/D3NR04147F

Reference256 articles.

1. Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise

2. The long story of camptothecin: From traditional medicine to drugs

3. Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing camptothecin loading and release control through physical surface modification of organosilica nanoparticles with polyethylene glycol;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-10

2. An Integrative Probe for Tumor Therapy and Dual-Modal Self-Evaluation Imaging of Therapeutic Efficacy;ACS Materials Letters;2024-09-05

3. USP37 protects mammalian cells during DNA replication stress by counteracting CUL2^LRR1and TRAIP;2024-09-03

4. FLI-1-driven regulation of endothelial cells in human diseases;Journal of Translational Medicine;2024-08-06

5. Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment;Frontiers in Pharmacology;2024-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3